Back to search
FDAFDA · Food and drugs·Recall number D-0885-2022

Losartan HCTZ 50/12.5 mg, 90 count bottle Original NDC# 33342-0050-10 Repackaged NDC# 70518-3231-00

Published June 1, 2022 · Recall initiated: May 4, 2022

Summary

FDA records drug Class II recall D-0885-2022, published June 1, 2022 and initiated May 4, 2022. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 22 bottles/90 count each; Lot: Lot # B1377711-100521, exp. date 10/31/2022 B1412137-102621, exp. date 10/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Recalled product was distributed to Florida.
Lot
Lot # B1377711-100521, exp. date 10/31/2022 B1412137-102621, exp. date 10/31/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Losartan HCTZ 50/12.5 mg, 90 count bottle Original NDC# 33342-0050-10 Repackaged NDC# 70518-3231-00 recalled?

Yes. FDA published recall D-0885-2022 on June 1, 2022. Reported hazard: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

What should I do if I have this product?

Voluntary: Firm initiated · Letter